Supply of Oncology Pharmaceuticals for Indian Army

The Department of Military Affairs, under the Ministry of Defence, is inviting bids for the supply of essential pharmaceutical products to the Indian Army. This tender, identified by Bid Number GEM/2026/B/7971559, is for a total quantity of 87 units. The specified items include Tab Darolutamide 300 mg (film-coated strip of 16 tablets), Tab Ivosidenib 250 mg (box of 60 tablets), Inj Dostarlimab concentrate for solution for infusion 500 mg per 10 ml, Inj Toripalimab 240mg per 6ml, Inj Tremelimumab concentrate for solution for infusion 300 mg per 15 ml, Tab Niraparib 100 mg (box of 56 tablets), Tab Brigatinib 90 mg (box of 28 tablets), Tab Brigatinib 180 mg (box of 28 tablets), and Tab Tucatinib 150 mg. Bidding will commence on November 15, 2026, at 11:00 AM and conclude on November 16, 2026, at 11:00 AM. Interested suppliers are requested to submit their proposals to the office located in Kolkata by the specified closing date.